The agency stated the deadlines were set to avoid unnecessary disruption to patient treatment. Semaglutides removal from the drug shortage list comes about 2 months after the FDA also confirmed that the shortage of tirzepatide (Mounjaro/Zepbound, Eli Lilly), another incretin-based drug for treating type 2 diabetes and obesity, was resolved
The medication is indicated for managing blood sugar levels (Ozempic and Rybelsus) and weight loss (Wegovy) when combined with a low-calorie diet and exercise
The gold standard for establishing cause-and-effect relationships is a randomized controlled trial
At The Doctors House in Edina, MN , we offer medically supervised weight loss programs , including innovative GLP-1 weight loss treatments , to help patients achieve safe, sustainable results
Not playing the price game when generics are coming in shows confidence in the product
If you find a routine that works, try to stick with it daily to maintain steady levels